Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New vaccine method could save millions
cow
In the past, BTV outbreaks have been able to spread for up to two years before a new vaccine could be developed.
Scientists find a way to fast-track the development of new Bluetongue vaccines

Glasgow scientists have found a faster way to produce vaccines for new strains of Bluetongue. The breakthrough could save the European economy millions by preventing the virus' devastating spread.

Bluetongue virus (BTV) has caused the deaths of thousands of livestock animals globally. It is spread by a certain type of midge and affects cattle, sheep and some other wild ruminants.

The outbreak of BTV-8 in 2008 is thought to have cost the Dutch economy around €80 million.

Traditionally, methods of prevention include culling of animals or the use of inactivated vaccines, which contain viruses killed by chemical methods.

While these vaccines have been a key tool in outbreaks across Europe over the past decade, they only prevent one strain of BTV. There are at least 26 different serotypes and when a new strain of the virus emerges, a new vaccine is usually required. In the past, BTV outbreaks have been able to spread for up to two years before a new vaccine could be developed.

Researchers from the University of Glasgow and Merial Animal Health have come up with a novel solution to the problem, which cuts design and production time by six months.

In the Journal of Virology, scientists explain how they have applied a "synthetic biology" approach, whereby synthetic viral particles are created in the laboratory. As the vaccine is not dependent on live, infectious viruses, it may be safer than current vaccines.

Lead researcher Massimo Palmarini, who is director of Glasgow's Centre for Virus Research, said: "Our findings demonstrate a clear advantage for the use of synthetic vaccine technology when compared with more traditional options.

"Overall, this vaccine platform can significantly reduce the time taken from the identification of newly emerging BTV strains to the development and production of new effective vaccines.

"They can be brought to the market more quickly but with the same level of quality and reliability as traditional vaccines. This is a big step towards a more sustainable, effective and rapid method of disease prevention."

Become a member or log in to add this story to your CPD history

Webinar to explore AMR in vet dentistry

News Story 1
 The WSAVA has invited veterinary professionals to a webinar on responsible antibiotic usage in dentistry.

On 19 November 2025, at 1am, Dr J Scott Weese and Dr Brooke Niemiec will share the latest advice for antimicrobial use. They will present research on oral bacterology, and explain how attendees can choose appropriate antibiotics.

The session will cover pre-, intra- and post-operative guidelines, with recommendations for various pathologies.

The webinar is designed to support veterinary professionals to make informed decisions and tackle antimicrobial resistance.

Attendees can register here

Click here for more...
News Shorts
Dechra launches checklist for veterinary sustainability

Global animal health specialist Dechra has announced the world's first Veterinary Green Theatre Checklist (VGTC) to help make surgery more sustainable.

Endorsed by leading veterinary organisations, including the BEVA, BVNA and RCVS Knowledge, the checklist is designed to reduce the environmental footprint of veterinary care, while supporting better animal health outcomes.

The checklist was launched at the World Congress of Veterinary Anaesthesia and Analgesia in Paris and will be followed by an internal training and awareness campaign. For more information, visit dechra.com